You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Azerbaijan

Feb 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer health records higher growth in 2011

Consumer health in Azerbaijan in 2011 experienced a higher growth rate in current value sales compared to both the previous year and to the review period as a whole. Growing domestic production, a government healthcare reform towards removing a ban on the advertising of OTC medicines, the development of chained retailers, widening the assortment of products available to increasingly sophisticated customers who have also become more aware of health trends affected consumer health right across the country towards the end of the review period, as well as increasing purchasing power and a rebound in consumer spending confidence.

Full television advertising and wider assortments prove essential

At the end of the review period, the government’s focus on pharmaceuticals increased, resulting in the restoration of advertising of OTC medicines through television, radio and other mass media assets. Febrofid, Voltaren, Linex, Imodium, Espumizan, Finalgon, Solpadeine, Coldrex, Pinosol, Doppelherz, Panadol, Comfort Kids, and Pikovit were the initial advertised brands through local television towards the end of the review period. Thus, the most successful of the leading players were those which invested in strong advertising or in broadening their distribution reach. GSK Azerbaijan Ltd notably supported its Solpadeine combination analgesics and Coldrex combination cough, cold and allergy (hay fever) remedies with strong advertising. Media coverage of healthcare issues strengthened in 2011 supported by the health and wellness trend, resulting in many consumers taking vitamins and dietary supplements on a regular basis. The growth of fitness centre chains and advertising of the MET-Rx brand in 2011 boosted sales of sports nutrition products.

Multinational players continue to dominate sales

The top-performing five international companies in Azerbaijan consumer health in 2011 were Actavis Group, Bristol-Myers Squibb Co, Marion Biotech Pvt Ltd, GSK Azerbaijan and Bayer AG. However, local companies have a presence in various topical analgesic ointments, herbal-based oils, skin care gels and creams. Local companies typically shape their strategic direction through licence agreements, and other forms of cooperation. These include Bioil Ltd, Herba-Flora Co and Azerfarma Ltd. Generic products also help local players to realise a presence in consumer health. Nevertheless, multinationals continue to dominate competition.

Chained parapharmacies expands its presence

Parapharmacies/drugstores continued to be the dominant distribution channel for consumer health at the end of the review period. Meanwhile, chained parapharmacies/drugstores continued to expand across the country, which included Zafaran Apteki, Lider Apteka, Trust Med, Logman Apteka, Dokta Apteka. Distribution of medicines remained strictly state-controlled and regulated by legislation. Convenience and timesaving are the key factors driving parapharmacies, as consumers have a chance to purchase toiletries, cosmetics, personal hygiene products there alongside medicinal products.

Upturn in constant value growth expected over forecast period

The continuous pursuit of preventative medication is expected to result in increased demand for products that improve wellbeing during the forecast period, as well as those that are based on herbal ingredients. Assortment will continue expanding in line with improving product quality and growing demand. Mass-media coverage focusing attention towards balanced nutritional issues will drive growth of vitamins and dietary supplements, digestive remedies, topical and systemic analgesics, and combination products - cough, cold and allergy (hay fever) remedies. Paediatric vitamins and dietary supplements will see continuous growth with more parents willing to prevent diseases caused by insufficient nutrition and the lack of calcium, magnesium, potassium or any other microelements or vitamins.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Azerbaijan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Azerbaijan, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Azerbaijan for free:

The Consumer Health in Azerbaijan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Azerbaijan?
  • What are the major brands in Azerbaijan?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Azerbaijan - Industry Overview

EXECUTIVE SUMMARY

Consumer health records higher growth in 2011

Full television advertising and wider assortments prove essential

Multinational players continue to dominate sales

Chained parapharmacies expands its presence

Upturn in constant value growth expected over forecast period

KEY TRENDS AND DEVELOPMENTS

Legislation changes lead to full television advertising being restored

Economic upturn positively impacts sales growth

Poor nutrition impacts vitamins and dietary supplements and weight management

Preventive medication drives consumer health

Baku is a high priority for consumer health players

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011

MARKET DATA

  • Table 2 Sales of Consumer Health by Category: Value 2006-2011
  • Table 3 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 4 Consumer Health Company Shares 2007-2011
  • Table 5 Consumer Health Brand Shares 2008-2011
  • Table 6 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 7 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 8 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 9 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

DISTRIBUTION

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

SWITCHES

SOURCES

  • Summary 1 Research Sources

Consumer Health in Azerbaijan - Company Profiles

Avita Shirketler Grupu in Consumer Health (Azerbaijan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Azerfarma Ltd in Consumer Health (Azerbaijan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Azerfarma Ltd: Competitive Position 2011

Repharma MMC in Consumer Health (Azerbaijan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, widening distribution in regions and growing consumer awareness of the products were one of the main drivers to maintain growth at a relatively high level. There is also some emerging trend which is related to the unwillingness of some consumers to visit dentists due to the high cost of dental treatment and long waiting times.

SWITCHES

COMPETITIVE LANDSCAPE

  • Unique Pharmaceutical Laboratories was the dominant player in adult mouth care in 2011 with a 32% value share. This was due to the company’s Metrogyl brand. The largest increase in current value share by two percentage points was also recorded by Unique Pharmaceutical Laboratories. This was due to its lower price which is convenient for price-sensitive consumers.

PROSPECTS

  • There is expected to be a growing focus on oral health during the forecast period. This will be linked to the growth of the grooming trend in Azerbaijan but will also be due to worsening oral health as a result of unhealthier diets.

CATEGORY DATA

  • Table 10 Sales of Adult Mouth Care: Value 2006-2011
  • Table 11 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 12 Adult Mouth Care Company Shares 2007-2011
  • Table 13 Adult Mouth Care Brand Shares 2008-2011
  • Table 14 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 15 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, analgesics sales were strongly determined by brand recognition and companies’ marketing efforts. Distributors relied on well-recognised brands with a good reputation. Companies were able to effectively manage marketing through advertising and work with pharmacies to increase brads recognition.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in analgesics continued to be Bristol-Myers Squibb Co, which held 21% value share in 2011 with its Cinepar brand. The brand leads systemic analgesics, where it accounted for 17% value share in 2011, while Levomokol Maz from Nizhpharm OAO leading topical analgesics/anaesthetic with 34% value share. Both brands benefit from comparatively cheaper prices, wide distribution via parapharmacies/drugstores, consumer loyalty and rapid relief.

PROSPECTS

  • Over the forecast period, analgesics sales will be fuelled by the high dependence on imports, population growth, improving living standards as well as the fact that consumers are switching to higher quality and less harmful analgesics.

CATEGORY DATA

Calming and Sleeping in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Intensive lifestyles, increasing stress levels, as well as increasing incidences of depression resulted in growing consumption of calming and sleeping products towards the end of the review period. Additionally, more advertisements of these products through television and posters, rising stress of urban living and working life also contributed to the growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Yaroslavskaya Farmatsevticheskaya Fabrika ZAO was a strong leader in calming and sleeping products in 2011 with 27% value share. The company’s Nastoyka pustirnika (motherwort tincture), and Nastoyka boyarishnika (aglet tincture) brands have a strong base of loyal customers since they are herbal-based, thus believing that they have no side effects.

PROSPECTS

  • Over the forecast period, calming and sleeping is expected to benefit from rising urbanisation and predicted economic growth in the country during the forecast period. Consumers are likely to lead increasingly stressful lifestyles, with many working longer hours. The expansion of retail chains will lead to growing availability of a wide assortment of calming and sleeping products. These factors will drive growth of the category over the forecast period.

CATEGORY DATA

  • Table 16 Sales of Calming and Sleeping: Value 2006-2011
  • Table 17 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 18 Calming and Sleeping Company Shares 2007-2011
  • Table 19 Calming and Sleeping Brand Shares 2008-2011
  • Table 20 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 21 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, cough, cold and allergy remedies continued to remain as seasonable products in Azerbaijan, with sales of cough and cold products increasing in the middle of the autumn and winter and sales of allergy products peaking in late spring and summer. The performance of the area usually depends on the severity of the winter and autumn seasons. However, during the beginning of October, the weather was warm which enabled flu and cough viruses to spread more easily. This resulted in consumers being more likely to buy cough, cold and allergy (hay fever) remedies at the first signs of illness, with this trend supporting strong sales. Acetaminophen with paracetamol as one of the main representatives is purchased mostly for reducing fever.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer AG was the leading player in 2011 and gained marginal value share to hold 13%. Bayer AG mainly benefited from the strong performance of its Nazol, Antiflu Kids, and Alka-Seltzer brands. Alka-Seltzer in combination products towards the end of the review period was positioned as being effective against any type of flu virus.

PROSPECTS

  • Over the forecast period, cough and cold remedies will see indirect competition from nutritional supplements. Consumers will attempt to understand that preventative treatments are a good way of avoiding long periods of sick leave. In addition, as a preventive method, consumers will also consider fruits enriched with vitamin C (orange, grapefruit, lemon and kiwi) as an effective way of staying healthy.

CATEGORY DATA

  • Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • During the review period, there was strong growth in sales for consumer foodservice in Azerbaijan, with fast food operated by Turkish and local businessmen and pizza consumer foodservice performing particularly well. This was chiefly due to the expansion of chains, with global brands such as McDonald’s and KFC proving largely successful among the younger generation. In addition, within the review period, there was strong growth for convenient packaged food, such as ready meals and sweet and savoury snacks, and for carbonates, driven by strong advertising and busier lifestyles. While these food products and beverages offer indulgence and a modern image, many find them to be more indigestible. Consequently, the growing popularity of fast food, convenience food and carbonates boosted sales of digestive remedies, as consumers sought to relieve uncomfortable symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Sanofi-Aventis was the leading player in digestive remedies, accounting for 18% value share and recording the largest increase in value sales by one percentage point. The company benefited from a strong portfolio of brands, including, Festal, Maalox, No-spa, and Nospalgin which are well-recognised by Azerbaijani consumers, especially No-spa which has been popular since the times of the former Soviet Union. During 2011, when the advertising of OTC medicines was approved, operators heavily invested in the massive advertising campaign which supported sales of Maalox and No-spa. Ukrmedprom DAK ranked second with 14% value share.

PROSPECTS

  • Over the forecast period, digestive remedies will continue to benefit from consumers’ changing lifestyles. Chained fast food players will continue to expand across the country, while consumers will be increasingly attracted by the convenience and indulgence offered by processed food and carbonates.

CATEGORY DATA

  • Table 28 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 29 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 30 Digestive Remedies Company Shares 2007-2011
  • Table 31 Digestive Remedies Brand Shares 2008-2011
  • Table 32 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 33 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Consumers are typically reluctant to self-medicate when it comes to ear-related problems, preferring to seek medical advice. This consequently results in prescription medicines dominating sales, with most likely to simply make repeat purchases of remedies that they were previously prescribed. Prescription ear care is widely available. Consequently, OTC ear care sales remained marginal in 2011 at AZN36, 420.

SWITCHES

COMPETITIVE LANDSCAPE

  • Aventis SA remained the leading player in ear care in 2011, with its Sofradex brand accounting for 44% value share. This brand has a long history in Azerbaijan and consequently benefits from wide distribution and strong awareness among ear care users.

PROSPECTS

  • A lack of investment in ear care will continue to limit sales during the forecast period. Players are reluctant to invest in new product development or advertising for ear care due to poor sales. However, poor sales are chiefly due to low consumer awareness. Consumers are generally sufficiently concerned about the threat of deafness or any other serious ear problem, so, prescription medicine within this area is highly preferred.

CATEGORY DATA

  • Table 34 Sales of Ear Care: Value 2006-2011
  • Table 35 Sales of Ear Care: % Value Growth 2006-2011
  • Table 36 Ear Care Company Shares 2007-2011
  • Table 37 Ear Care Brand Shares 2008-2011
  • Table 38 Forecast Sales of Ear Care: Value 2011-2016
  • Table 39 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Azerbaijan - Category Analysis

TRENDS

  • No OTC emergency contraception was available in Azerbaijan at the end of the review period as all medicines were Rx only.

Eye Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • During the review period, there was growing popularity for contact lenses, as these became more widely available in Azerbaijan and also more affordable. Rising disposable income levels encouraged consumers to invest more in their appearance, which resulted in many switching from glasses to contact lenses. In addition, longer office working hours resulted in recovery in eye care demand which in turn led to price adjustments.

SWITCHES

COMPETITIVE LANDSCAPE

  • Multinationals dominate eye care in 2011. In GBO terms, World Medicine LLC ranked first with a value share of over 19% of eye care sales in 2011. Novartis AG followed with 14%. Normatin and Bestoxol brands are recommended by ophthalmologists. Those brands benefited from strong brand recognition and growth in its base of loyal customers.

PROSPECTS

  • Over the forecast period, ongoing strong growth is expected in the use of contact lenses and computers in Azerbaijan, with this underpinned by rising disposable income levels as the country’s economy grows. Computer usage is expected to increase dramatically, both in terms of frequency and the number of those using computers on a regular basis. This will be partly due to growth in services and urbanisation, with a growing number of Azerbaijanis working in modern offices and using computers.

CATEGORY DATA

  • Table 40 Sales of Eye Care by Category: Value 2006-2011
  • Table 41 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 42 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 43 Standard Eye Care by Positioning 2007-2011
  • Table 44 Eye Care Company Shares 2007-2011
  • Table 45 Eye Care Brand Shares 2008-2011
  • Table 46 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 47 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, there was growing awareness of and an interest in herbal/traditional products. This was partially attributable to the widening distribution of products and higher sales performance of herbal/traditional cough, cold and allergy (hay fever) remedies and calming and sleeping products. In addition, this trend was encouraged by consumer concerns about the potentially hazardous side effects associated with standard OTC products and the misuse of Rx medicines.

COMPETITIVE LANDSCAPE

  • Plethico Pharmaceuticals Ltd led sales of herbal/traditional products in 2011 with 15% value share. Its Travisil brand remains popular among consumers for coughing problems. However, it lost half a percentage point compared to the previous year. This was due to the appearance of other standard OTC brands marketed to relieve cough problems.

PROSPECTS

  • Over the forecast period, the strong tradition of herbal medicine in Azerbaijan is expected to receive growing attention. In parallel, the leading chains in parapharmacies/drugstores are also expected to expand. The government is expected to encourage the development of a wider range of domestic herbal/traditional products, due to their affordable nature, with these likely to obtain strong distribution via parapharmacies/drugstores.

CATEGORY DATA

  • Table 48 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 49 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 50 Herbal/Traditional Products Company Shares 2007-2011
  • Table 51 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 52 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 53 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Azerbaijani consumers place considerable emphasis on appearance and a well-groomed appearance is symbolic of social status and career success. Medicated skin care was boosted by the continuous very hot summer in 2011, which resulted in many of those suffering from skin disorders experiencing stronger symptoms. Allergies, pruritus, acne, head and body lice infestations, foot fungus and haemorrhoids are frequent ailments within this area. Consequently, many consumers began to use medicated skin care with greater frequency in order to alleviate their symptoms.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading player in medicated skin care in GBO terms is Protec Pharmaceuticals Ltd, which held nearly 10% value share in 2011. This company offers a wide range of medicated skin care, including Erythromicini in vaginal antifungals, Gentamycini and Synthomycini in topical germicidals/antiseptics. The company benefits from this wide range and also from its well-trusted brands.

PROSPECTS

  • Over the forecast period, consumer attitudes will continue to evolve during the forecast period and medicated skin care is expected to see strong growth. With the spread in internet coverage, the ongoing spread of modern chained chemists/pharmacies across the country, and more literature available on common disorders, consumers will become more aware of the treatments on offer.

CATEGORY DATA

  • Table 54 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 55 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 56 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 57 Medicated Skin Care Brand Shares 2008-2011
  • Table 58 Hair Loss Treatments Brand Shares 2008-2011
  • Table 59 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, the discussions at the National Parliament continued with protests coming from various parties which lobby restaurant and coffeehouse owners. However, tougher smoking bans in public places with fixed penalties for flouting the law and the assignment of a relative authority to control this, is expected to be enforced.

SWITCHES

COMPETITIVE LANDSCAPE

  • The Nicorette brand by GSK Azerbaijan remained the absolute leader in NRT smoking cessation aids category in 2011 accounting for 100% of retail value sales.

PROSPECTS

  • Smokers usually start making an effort to stop smoking encouraged by economic or public opinion stimulus. Tightening legislation and a spread of healthy lifestyles in line with economic stimulus will support a stable performance of the category over the forecast period with a CAGR of 2% in constant value terms anticipated, which is higher than the decline of 4% achieved during the review period.

CATEGORY INDICATORS

  • Table 61 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 62 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 63 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 64 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 65 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 66 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 67 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 68 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, many loyal customers reduced their consumption of sports nutrition products due to the economic downturn and uncertainty over income. Extremely warm weather during the summer of 2011 also lowered everyday activities of many fitness club members, with many people trying to leave cities to visit the countryside and therefore missing their training. This led to lowered consumption of sports nutrition.

COMPETITIVE LANDSCAPE

  • Ultimate Nutrition Inc led sports nutrition in 2011 with 46% value share. Its brand has been available in Azerbaijan for many years and has gained loyal customers and the respect of professionals. Its high quality, wider distribution and standard price made it a top-selling brand. The biggest increase in value share was also recorded by Ultimate Nutrition with three percentage points over the previous year. Increased quality and distribution provided a background for sales of the company’s products.

PROSPECTS

  • The development of fitness centres chains, growth of distribution and widening assortment will continue to drive growth. Increasing sports activity will result in a wider range of consumers becoming familiar with sports nutrition. Economic recovery will lead to an increase in purchasing power.

CATEGORY DATA

  • Table 69 Sales of Sports Nutrition: Value 2006-2011
  • Table 70 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 71 Sports Nutrition Company Shares 2007-2011
  • Table 72 Sports Nutrition Brand Shares 2008-2011
  • Table 73 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 74 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • In 2011, vitamins and dietary supplements witnessed increasing demand in the everyday consumption, with supplements taken by many consumers as a preventative daily measure. Consumers became increasingly focused on nutrition and interested in the role that vitamins and dietary supplements plays, with this encouraged by growing media coverage. This supported an impressive 14% current value in 2011 in vitamins and dietary supplements as a whole, although some of this growth was also due to the level of inflation.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • In 2011, Actavis Group remained the leading player in vitamins and dietary supplements with 21% value share; however the operator lost half a percentage point mostly due to the expansion of other operators within single vitamins where Actavis has been active. Despite this decrease in value share, its leadership is largely to strong distribution.

PROSPECTS

  • Vitamins and dietary supplements is expected to strongly benefit from two main factors during the forecast period. Firstly, there is expected to be a growing interest in health and nutrition, with consumers increasingly focusing on optimum health rather than simply treating the symptoms of disease. Secondly, a return to economic growth will result in consumers having more money to spend on vitamins and dietary supplements.
  • Summary 7 Dietary Supplements: Brand Ranking by Positioning 2011

CATEGORY DATA

  • Table 75 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 76 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 77 Dietary Supplements by Positioning 2007-2011
  • Table 78 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 79 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 80 Vitamins Brand Shares 2008-2011
  • Table 81 Dietary Supplements Brand Shares 2008-2011
  • Table 82 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 83 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Consumers in Azerbaijan are increasingly focused on losing weight. Lack of dynamics and imbalanced diets are leading to obesity among many urban dwellers in Azerbaijan. At the end of the review period, a wide assortment of convenient weight-loss products appeared locally. The supply was supported by growing economic growth, authorised advertising of such products through television and other mass media and increasing purchasing power of the targeted audience.

COMPETITIVE LANDSCAPE

  • Domestic Herba-Flora Co led sales in 2011 with 37% value share in 2011 despite a marginal decline over the previous year. In this category, the operator only specialises in slimming teas, although it has the longest presence in Azerbaijan weight management. Its products are widely known. It benefits from affordable prices, solid recognition, quality products and wider distribution coverage.

PROSPECTS

  • The number of overweight people in Azerbaijan will continue to grow towards the end of the forecast period. An extremely low percentage of them are active in sports in the country which combined with imbalanced diets, causes them to become overweight. The promotion of healthier lifestyles through mass media and increasing incomes will provide demand growth. The image of weight loss supplements and coffee-based weight management products will improve and the customer base will widen.

CATEGORY DATA

  • Table 84 Sales of Weight Management by Category: Value 2006-2011
  • Table 85 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 86 Weight Management Company Shares 2007-2011
  • Table 87 Weight Management Brand Shares 2008-2011
  • Table 88 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 89 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • In 2011, rising economic confidence resulted in many consumers stocking up on wound care, which is considered to useful and antiseptic products to use in case of accidents. However, towards the end of the review period, wound care remained a mature category featuring products such as bandages, plasters and cotton wool being produced for many years. Innovative formats, such as gels and sprays, were still not present in the country at the end of the review period.

COMPETITIVE LANDSCAPE

  • Seyitler Kimya AS led wound care in 2011 with 35% value share with its Pelikan brand. The company’s sticking plasters/adhesive bandages are priced at a lower level, are widely available and popular within consumers.

PROSPECTS

  • Wound care is expected to display a 4% constant value CAGR during the forecast period, which will represent an improvement from the -5% constant value CAGR of the review period. Affordable brands such as Pelikan, Santavik, and Adhesan are expected to launch a wider range of specialist products, in an attempt to attract consumers away from higher-priced global brands. Consequently, there is expected to be little change in constant value unit price during the forecast period.

CATEGORY DATA

  • Table 90 Sales of Wound Care by Category: Value 2006-2011
  • Table 91 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 92 Wound Care Company Shares 2007-2011
  • Table 93 Wound Care Brand Shares 2008-2011
  • Table 94 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 95 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!